202 related articles for article (PubMed ID: 24487688)
21. Lactate dehydrogenase downregulation mediates the inhibitory effect of diallyl trisulfide on proliferation, metastasis, and invasion in triple-negative breast cancer.
Cheng SY; Yang YC; Ting KL; Wen SY; Viswanadha VP; Huang CY; Kuo WW
Environ Toxicol; 2017 Apr; 32(4):1390-1398. PubMed ID: 27566995
[TBL] [Abstract][Full Text] [Related]
22. Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfide.
Kim SH; Singh SV
Mol Carcinog; 2022 Aug; 61(8):752-763. PubMed ID: 35512572
[TBL] [Abstract][Full Text] [Related]
23. Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC).
Liu Y; Zhao Y; Wei Z; Tao L; Sheng X; Wang S; Chen J; Ruan J; Liu Z; Cao Y; Shan Y; Wang A; Chen W; Lu Y
Cell Physiol Biochem; 2018; 50(5):1945-1963. PubMed ID: 30396169
[TBL] [Abstract][Full Text] [Related]
24. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
[TBL] [Abstract][Full Text] [Related]
25. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.
Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV
J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776
[TBL] [Abstract][Full Text] [Related]
26. Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1.
Na HK; Kim EH; Choi MA; Park JM; Kim DH; Surh YJ
Biochem Pharmacol; 2012 Nov; 84(10):1241-50. PubMed ID: 22981381
[TBL] [Abstract][Full Text] [Related]
27. Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-α-induced Triple Negative Breast Cancer Cells.
Kanga KJW; Kanga LHB; Mendonca P; Soliman KFA; Ferguson DT; Reed SL; Darling-Reed S
Anticancer Res; 2023 Jun; 43(6):2393-2405. PubMed ID: 37247921
[TBL] [Abstract][Full Text] [Related]
28. Diallyl trisulfide suppresses tumor growth through the attenuation of Nrf2/Akt and activation of p38/JNK and potentiates cisplatin efficacy in gastric cancer treatment.
Jiang XY; Zhu XS; Xu HY; Zhao ZX; Li SY; Li SZ; Cai JH; Cao JM
Acta Pharmacol Sin; 2017 Jul; 38(7):1048-1058. PubMed ID: 28344324
[TBL] [Abstract][Full Text] [Related]
29. Diallyl disulfide and diallyl trisulfide up-regulate the expression of the pi class of glutathione S-transferase via an AP-1-dependent pathway.
Tsai CW; Chen HW; Yang JJ; Sheen LY; Lii CK
J Agric Food Chem; 2007 Feb; 55(3):1019-26. PubMed ID: 17263507
[TBL] [Abstract][Full Text] [Related]
30. Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo.
Chandra-Kuntal K; Singh SV
Cancer Prev Res (Phila); 2010 Nov; 3(11):1473-83. PubMed ID: 20959517
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms for the anti-cancer effects of diallyl disulfide.
Yi L; Su Q
Food Chem Toxicol; 2013 Jul; 57():362-70. PubMed ID: 23583486
[TBL] [Abstract][Full Text] [Related]
32. Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein.
Lei YP; Liu CT; Sheen LY; Chen HW; Lii CK
Mol Nutr Food Res; 2010 May; 54 Suppl 1():S42-52. PubMed ID: 20229525
[TBL] [Abstract][Full Text] [Related]
33. A proteomic study on a human osteosarcoma cell line Saos-2 treated with diallyl trisulfide.
Zhang YK; Zhang XH; Li JM; Sun DS; Yang Q; Diao DM
Anticancer Drugs; 2009 Sep; 20(8):702-12. PubMed ID: 19550292
[TBL] [Abstract][Full Text] [Related]
34. Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals.
Chen C; Pung D; Leong V; Hebbar V; Shen G; Nair S; Li W; Kong AN
Free Radic Biol Med; 2004 Nov; 37(10):1578-90. PubMed ID: 15477009
[TBL] [Abstract][Full Text] [Related]
35. Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2.
Xiao D; Li M; Herman-Antosiewicz A; Antosiewicz J; Xiao H; Lew KL; Zeng Y; Marynowski SW; Singh SV
Nutr Cancer; 2006; 55(1):94-107. PubMed ID: 16965246
[TBL] [Abstract][Full Text] [Related]
36. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
Xiao D; Choi S; Johnson DE; Vogel VG; Johnson CS; Trump DL; Lee YJ; Singh SV
Oncogene; 2004 Jul; 23(33):5594-606. PubMed ID: 15184882
[TBL] [Abstract][Full Text] [Related]
37. Diallyl trisulfide potentiates chemotherapeutic efficacy of doxorubicin in experimentally induced mammary carcinoma: Role of Notch signaling.
Elsherbiny NM; El-Sherbiny M; Zaitone SA
Pathol Res Pract; 2020 Oct; 216(10):153139. PubMed ID: 32853959
[TBL] [Abstract][Full Text] [Related]
38. Effect of Diallyl Trisulfide on TNF-α-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells.
Kanga KJW; Mendonca P; Soliman KFA; Ferguson DT; Darling-Reed SF
Anticancer Res; 2021 Dec; 41(12):5919-5933. PubMed ID: 34848446
[TBL] [Abstract][Full Text] [Related]
39. Diallyl trisulfide induces apoptosis and mitotic arrest in AGS human gastric carcinoma cells through reactive oxygen species-mediated activation of AMP-activated protein kinase.
Choi YH
Biomed Pharmacother; 2017 Oct; 94():63-71. PubMed ID: 28753455
[TBL] [Abstract][Full Text] [Related]
40. Diallyl trisulfide induces apoptosis of human basal cell carcinoma cells via endoplasmic reticulum stress and the mitochondrial pathway.
Wang HC; Hsieh SC; Yang JH; Lin SY; Sheen LY
Nutr Cancer; 2012; 64(5):770-80. PubMed ID: 22519436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
